Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Travere Therapeutics Insider Sold Shares Worth $2,337,695, According to a Recent SEC Filing

Travere Therapeutics Insider Sold Shares Worth $2,337,695, According to a Recent SEC Filing

MT newswireMT newswire2026/09/18 07:44
03:44 AM EDT, 09/18/2026 (MT Newswires) -- Elizabeth E Reed, Chief Legal Officer and General Counsel, on September 15, 2026, sold 37,500 shares in Travere Therapeutics (TVTX) for $2,337,695. Following the Form 4 filing with the SEC, Reed has control over a total of 105,389 common shares of the company, with 105,389 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1438533/000128330326000010/xslF345X05/form4-09182026_010948.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!